David F Melcher bought $178k of EMBC
director at Embecta Corp.. 13,000 shares at an average of $13.67, traded Feb 25, 2025, filed Feb 25, 2025.
Score components
- +15RoleDirector
- +12Trade size$178k at market
- +6Relative to holdingsHoldings up 20%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000947871-25-000221, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 25, 2025 | POpen-market purchase Common Stock | +13,000 | $13.67 | $178k | 76,681 | Feb 25, 2025 |
Related signals
Other insiders at Embecta Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 26Weak | EMBCsell Embecta Corp. | Milton Mayo Morris director | $37k 6,293 shares | -10% | |
| 51Moderate | EMBCbuy Embecta Corp. | David F Melcher director | $106k 10,000 shares | +13% | |
| 22Weak | EMBCsell Embecta Corp. | Milton Mayo Morris director | $51k 3,100 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.